24 May 2013
Keywords: xenoport, exercises, option, co-market, solzira, usa, gsk
Article | 16 April 2009
US drugmaker XenoPort has exercised the option contained in its deal with UK drug major GlaxoSmithKline to co-promote and share ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 April 2009
17 April 2009
23 May 2013
© 2013 thepharmaletter.com